S
Stuart M. Lichtman
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 187
Citations - 8769
Stuart M. Lichtman is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 41, co-authored 171 publications receiving 7173 citations. Previous affiliations of Stuart M. Lichtman include North Shore-LIJ Health System & PSL Research University.
Papers
More filters
Journal ArticleDOI
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria,Kayo Togawa,Supriya G. Mohile,Cynthia Owusu,Heidi D. Klepin,Cary P. Gross,Stuart M. Lichtman,Ajeet Gajra,Smita Bhatia,Vani Katheria,S. Klapper,Kurt Hansen,Rupal Ramani,Mark S. Lachs,F. Lennie Wong,William P. Tew +15 more
TL;DR: A risk stratification schema can establish the risk of chemotherapy toxicity in older adults and Geriatric assessment variables independently predicted therisk of toxicity.
Journal ArticleDOI
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
Martine Extermann,Matti Aapro,Roberto Bernabei,Harvey J. Cohen,Jean Pierre Droz,Stuart M. Lichtman,Vincent Mor,Silvio Monfardini,Lazzaro Repetto,Liv Wergeland Sørbye,Eva Topinkova +10 more
TL;DR: A CGA, with or without screening, and with follow-up, should be used in older cancer patients, in order to detect unaddressed problems, improve their functional status, and possibly their survival.
Journal ArticleDOI
Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: Asco guideline for geriatric oncology
Supriya G. Mohile,William Dale,Mark R. Somerfield,Mara A. Schonberg,Cynthia M. Boyd,Peggy S. Burhenn,Beverly Canin,Harvey J. Cohen,Holly M. Holmes,Judith O. Hopkins,Michelle C. Janelsins,Alok A. Khorana,Heidi D. Klepin,Stuart M. Lichtman,Karen M. Mustian,William P. Tew,Arti Hurria +16 more
TL;DR: Geriatric assessment (GA) should be used to identify vulnerabilities that are not routinely captured in oncology assessments and clinicians should take into account GA results when recommending chemotherapy.
Journal ArticleDOI
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S. Kim,Suanna S. Bruinooge,Samantha A. Roberts,Gwynn Ison,Nan Lin,Lia Gore,Thomas S. Uldrick,Stuart M. Lichtman,Nancy Roach,Julia A. Beaver,Rajeshwari Sridhara,Paul J. Hesketh,Andrea M. Denicoff,Elizabeth Garrett-Mayer,Eric J. Rubin,Pratik S. Multani,Tatiana M. Prowell,Caroline Schenkel,Marina Kozak,Jeff Allen,Ellen V. Sigal,Richard L. Schilsky +21 more
TL;DR: To maximize generalizability of results, trial enrollment criteria should strive for inclusiveness and Rationale for excluding patients should be clearly articulated and reflect expected toxicities associated with the therapy under investigation.
Journal ArticleDOI
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
Arti Hurria,Laura A. Levit,William Dale,Supriya G. Mohile,Hyman B. Muss,Louis Fehrenbacher,Allison Magnuson,Stuart M. Lichtman,Suanna S. Bruinooge,Enrique Soto-Perez-de-Celis,William P. Tew,Michael A. Postow,Harvey J. Cohen +12 more
TL;DR: The American Society of Clinical Oncology convened a subcommittee to develop recommendations on improving the evidence base for treating older adults with cancer in response to a critical need identified by the Institute of Medicine.